UNSPSC 51152404: Aspirin/methocarbamol

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class MS200. This VA Drug Class (MS200) classifies this compound as belonging to the group SKELETAL MUSCLE RELAXANTS.

UNSPSC 51152404 Aspirin/methocarbamol is a Commodity code showing minimal recent state and local procurement activity aligned with its nominal scope. The two recent opportunities tagged to this code—a Seminole County, Florida IFB for Naloxone and drug deactivation systems, and a Texas Health and Human Services Commission RFI for direct-to-manufacturer prescription fulfillment—do not reflect purchases of aspirin or methocarbamol products. The mismatch suggests either miscoding in the issuing bodies' procurement systems or that the code is being used as a catch-all for pharmaceutical procurement when more specific pharmaceutical codes are unavailable or not applied. State and local governments do procure over-the-counter and prescription medications for health departments, EMS systems, corrections facilities, and employee health plans, but the recent record under this specific code does not demonstrate active demand for aspirin or methocarbamol formulations.

Opportunities posted under the code span Florida and Texas, with Seminole County pursuing naloxone on an IFB basis due July 26, 2023 (with a posted date of June 30, 2026, indicating potential record-management inconsistency), and the Texas HHS Commission conducting market intelligence through an RFI posted April 3, 2026. Neither opportunity targets the pharmaceutical products nominally covered by the code. Vendors tracking this code for aspirin or methocarbamol procurement should monitor whether issuing bodies begin tagging opportunities to more granular pharmaceutical commodity codes or whether mislabeling persists; the current record suggests watch-and-wait positioning rather than active pursuit under this Commodity designation.